Newsfeeds - Spark Newswire

2 minute read

Media
News

Elon Musk A Frequent Flier In 2022 With Flights Lasting As Little As 13 Minutes, Says Report: His Love For Jet-Setting At Odds With Tesla’s Climate Stance?

Today, 11:21 AM

Tesla Inc. (NASDAQ: TELA) CEO Elon Musk is an entrepreneur who has his fingers in many pies, and undoubtedly time is money for him.

TELA

1 minute read

JMP Securities Maintains Market Outperform on TELA Bio, Lowers Price Target to $20

By Benzinga Newsdesk

Today, 11:21 AM

JMP Securities analyst David Turkaly maintains TELA Bio (NASDAQ:TELA) with a Market Outperform and lowers the price target from $22 to $20.

TELA

1 minute read

Piper Sandler Maintains Overweight on TELA Bio, Lowers Price Target to $15

By Benzinga Newsdesk

Today, 11:21 AM

Piper Sandler analyst Matt O'Brien maintains TELA Bio (NASDAQ:TELA) with a Overweight and lowers the price target from $20 to $15.

TELA

1 minute read

Earnings

Earnings Outlook For TELA Bio

By Benzinga Insights

Today, 11:21 AM

TELA Bio (NASDAQ:TELA) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that TELA Bio will report an earnings per share (EPS) of $-0.63.

TELA

1 minute read

Earnings

Recap: TELA Bio Q2 Earnings

By Benzinga Insights

Today, 11:21 AM

TELA Bio (NASDAQ:TELA) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:01 PM. Here's what investors need to know about the announcement.

TELA

11 minute read

Earnings Scheduled For August 10, 2022

By Benzinga Insights

Today, 11:21 AM

Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is estimated to report earnings for its second quarter.

AADI

1 minute read

Earnings

Earnings Preview For TELA Bio

By Benzinga Insights

Today, 11:21 AM

TELA Bio (NASDAQ:TELA) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement. Analysts estimate that TELA Bio will report an earnings per share (EPS) of $-0.62.

TELA

1 minute read

TELA Bio Earlier Highlighted Results From BRAVO And ReBAR Studies On The Benefits Of OviTex Reinforced Tissue Matrix In Hernia Repairs; Data To Be Presented At 2022 American Hernia Society (AHS) Meeting

By Benzinga Newsdesk

Today, 11:21 AM

24-Month BRAVO study results showed a 2.6% recurrence rate in diverse clinical scenarios Robotic Reinforced Biologic Augmented Repair (ReBAR) study showed a 1.9% recurrence rate at two-year

TELA

2 minute read

TELA Bio Announces Up To $50M In Debt Financing From MidCap Financial

By Bill Haddad

Today, 11:21 AM

TELA Bio, Inc. ("TELA") (NASDAQ:TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the

TELA

44 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 11:21 AM

On Wednesday, 807 companies reached new 52-week lows.

AADI